These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32180716)

  • 1. Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation.
    Lai J; Luo X; Tian S; Zhang X; Huang S; Wang H; Li Q; Cai S; Chen Q
    Front Pharmacol; 2020; 11():88. PubMed ID: 32180716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.
    Gao D; Li T; Li XD; Chen X; Li QZ; Wight-Carter M; Chen ZJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5699-705. PubMed ID: 26371324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice.
    An J; Woodward JJ; Lai W; Minie M; Sun X; Tanaka L; Snyder JM; Sasaki T; Elkon KB
    Arthritis Rheumatol; 2018 Nov; 70(11):1807-1819. PubMed ID: 29781188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus.
    An J; Durcan L; Karr RM; Briggs TA; Rice GI; Teal TH; Woodward JJ; Elkon KB
    Arthritis Rheumatol; 2017 Apr; 69(4):800-807. PubMed ID: 27863149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP.
    Maltbaek JH; Cambier S; Snyder JM; Stetson DB
    Immunity; 2022 Oct; 55(10):1799-1812.e4. PubMed ID: 36070769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.
    Wiser C; Kim B; Vincent J; Ascano M
    Sci Rep; 2020 May; 10(1):7604. PubMed ID: 32371942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.
    Hu Y; Chen B; Yang F; Su Y; Yang D; Yao Y; Wang S; Wu Y; Tao L; Xu T
    Autoimmun Rev; 2022 Sep; 21(9):103155. PubMed ID: 35902046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
    García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
    Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C
    Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway.
    Bose D; Su Y; Marcus A; Raulet DH; Hammond MC
    Cell Chem Biol; 2016 Dec; 23(12):1539-1549. PubMed ID: 27889408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A STING to inflammation and autoimmunity.
    Kumar V
    J Leukoc Biol; 2019 Jul; 106(1):171-185. PubMed ID: 30990921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression.
    Ma XY; Chen MM; Meng LH
    Acta Pharmacol Sin; 2024 May; 45(5):890-899. PubMed ID: 38177693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.
    Deb P; Dai J; Singh S; Kalyoussef E; Fitzgerald-Bocarsly P
    J Immunol; 2020 Jul; 205(1):223-236. PubMed ID: 32471881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel DCPIB analogs as dual inhibitors of VRAC/TREK1 channels reduced cGAS-STING mediated interferon responses.
    Zhi Y; Liu J; Kuang P; Zhang X; Xu Z; Chen Y; Lin X; Wu X; Zhou P; Chen J
    Biochem Pharmacol; 2022 May; 199():114988. PubMed ID: 35278418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive oligodeoxynucleotides containing TTAGGG motifs inhibit cGAS activation in human monocytes.
    Steinhagen F; Zillinger T; Peukert K; Fox M; Thudium M; Barchet W; Putensen C; Klinman D; Latz E; Bode C
    Eur J Immunol; 2018 Apr; 48(4):605-611. PubMed ID: 29215161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.
    Pan M; Hu T; Lyu J; Yin Y; Sun J; Wang Q; Xu L; Hu H; Wang C
    Autophagy; 2024 Feb; 20(2):311-328. PubMed ID: 37723657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling.
    Mohamud Y; Fu C; Fan YM; Zhang YL; Lin JFC; Hwang SW; Wang ZC; Luo H
    Antiviral Res; 2024 Feb; 222():105811. PubMed ID: 38242503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.